Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NC/Fayetteville
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fayetteville, NC

Studies commonly pay $75 to $4,500 per completed study

121 clinical trials are currently recruiting participants within 30 miles of Fayetteville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

121studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Fayetteville right now

Top 25 of 121 recruiting studies, sorted by proximity — each links to its official registry page

ERP to Improve Functioning in Veterans With OCD

Obsessive Compulsive Disorder (OCD), Comorbid Post-Traumatic Stress Disorder and OCD N/A Interventional 160 participants sought
Fayetteville VA Medical Center, Fayetteville, NC — Fayetteville, North Carolina (6.0 mi) · Sponsor: VA Office of Research and Development

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Pancreatic Cancer, Pancreatic Cancer Metastatic Phase 3 Interventional 570 participants sought
FirstHealth of the Carolinas — Pinehurst, North Carolina (28.8 mi) · Sponsor: Immuneering Corporation

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus Phase 2 Interventional 405 participants sought
Cross Creek Medical Clinic, PA — Fayetteville, North Carolina (6.0 mi) · Sponsor: Boehringer Ingelheim

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Phase 3 Interventional 1,295 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Ovarian Cancer, Fallopian Tube Cancer Phase 3 Interventional 770 participants sought
FirstHealth Cancer Center ( Site 0079) — Pinehurst, North Carolina (28.8 mi) · Sponsor: Merck Sharp & Dohme LLC

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi) · Sponsor: SWOG Cancer Research Network

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis Phase 3 Interventional 1,350 participants sought
89bio Clinical Study Site — Fayetteville, North Carolina (6.0 mi) · Sponsor: Hoffmann-La Roche

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Heart Failure Phase 3 Interventional 4,200 participants sought
Pinehurst Medical Clinic, Inc. - East — Pinehurst, North Carolina (28.8 mi) · Sponsor: Boehringer Ingelheim

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Obesity, Overweight Phase 3 Interventional 3,600 participants sought
ACCOMPLISH-1 Research Site — Fayetteville, North Carolina (6.0 mi) · Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma Phase 2, Phase 3 Interventional 189 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi) · Sponsor: National Cancer Institute (NCI)

Comparative Performance of a Vaginal Yeast Test

Vulvovaginal Candidiasis N/A Observational 1,200 participants sought
Womack Army Medical Center — Fort Bragg, North Carolina (4.1 mi) · Sponsor: Uniformed Services University of the Health Sciences

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 2,400 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi) · Sponsor: SWOG Cancer Research Network

Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis

Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital Phase 3 Interventional 400 participants sought
Cross Creek Medical Clinic, PA — Fayetteville, North Carolina (6.0 mi) · Sponsor: pH-D Feminine Health LLC

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Breast Cancer N/A Observational 1,800 participants sought
FirstHealth Outpatient Cancer Center — Pinehurst, North Carolina (28.8 mi) · Sponsor: Exact Sciences Corporation

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease Phase 2 Interventional 42 participants sought
GSK Investigational Site — Fayetteville, North Carolina (6.0 mi) · Sponsor: GlaxoSmithKline

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

Excessive Sleepiness, Shift-work Disorder Phase 3 Interventional 520 participants sought
Clinical Research Site — Fayetteville, North Carolina (6.0 mi) · Sponsor: Axsome Therapeutics, Inc.

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Prostate Cancer (Adenocarcinoma) Phase 3 Interventional 830 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi) · Sponsor: Canadian Cancer Trials Group

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
Javara Inc. — Fayetteville, North Carolina (6.0 mi) · Sponsor: Duke University

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

COPD (Chronic Obstructive Pulmonary Disease) Phase 3 Interventional 5,250 participants sought
Research Site — Fayetteville, North Carolina (6.0 mi) · Sponsor: AstraZeneca

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Bronchiectasis Phase 3 Interventional 1,755 participants sought
Pinehurst Medical Clinic, Inc. - East — Pinehurst, North Carolina (28.8 mi) · Sponsor: Boehringer Ingelheim

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma Phase 3 Interventional 382 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis Phase 3 Interventional 1,800 participants sought
Coastal Research Institute, LLC — Fayetteville, North Carolina (6.0 mi) · Sponsor: Boehringer Ingelheim
Actively enrolling

Studies you may be able to join near Fayetteville

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Fayetteville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Coastal Research Institute

★ 5.0
2139 Valleygate Dr Ste 101B, Fayetteville, NC 28304
(910) 500-3146
"Super friendly and knowledgeable staff. The process was quick. I am<br>Happy I came and gained a bit more knowledge about myself and the studies they…"
— Leona Flinn, 5★

Cumberland Research Associates

2109 Valleygate Dr Ste 102, Fayetteville, NC 28304
(910) 484-8163

Clinical Counseling and Consulting Services, PLLC Assessment and Treatment Center

★ 2.5 (38 reviews)
2931 Breezewood Ave #200, Fayetteville, NC 28303
(910) 748-0833
"I am so surprised at the reviews. We have had a great experience with this place. My daughter is an intellectually disabled adult and we recently mov…"
— Jeana M, 5★

North Carolina Clinical Research

★ 5.0
2615 Lake Dr #301, Raleigh, NC 27607
(919) 881-0309
"I donated my brain here. I think..."
— Scott B, 5★

Superior Clinical Research, LLC

★ 4.8
712 Wilkins St Ste C, Smithfield, NC 27577
(919) 938-8058
"I just started the diabetic research. I'm on my 5 th week now and looking forward in completing the program so I can be able to help others with the …"
— Venis Mcneill, 4★

Duke Clinical Research Institute

★ 4.9
300 W Morgan St, Durham, NC 27701
(919) 668-8700
"Great awesome place to work!! Loved it❤"
— Ramona Williams, 5★

M3 Wake Research Raleigh

★ 4.3
3100 Duraleigh Rd, Raleigh, NC 27612
(919) 781-2514
"Is it really that hard to return a call? I was really excited about this clinical trial. At this point, I have no choice but to assume that your sile…"
— 1TiredWoman!, 1★

Rose Research Center

★ 4.3
7240 ACC Blvd, Raleigh, NC 27617
(919) 328-2345
"Very clean facility. They're always telling me that I don't qualify for their studies for whatever reason but I feel like it's because I dropped out …"
— Rita Poole, 4★

UNC CTRC (Clinical & Translational Research Center)

★ 5.0
Burnett-Womack Building, 160 Dental Cir, Chapel Hill, NC 27514
(919) 966-1437

Clinical trials in Fayetteville: what's recruiting

The Fayetteville area currently has 121 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fayetteville, the most active research areas are:

  • Cancer & Oncology11 studies
  • Diabetes & Metabolism4 studies
  • Liver & Kidney4 studies
  • Heart & Vascular2 studies
  • Lungs & Breathing2 studies

Every listing shows the study phase, the recruiting site and its distance from Fayetteville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fayetteville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fayetteville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fayetteville pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Fayetteville safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Fayetteville, NC?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Fayetteville?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Fayetteville?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fayetteville.

Paid clinical trials near Fayetteville

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of NC

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts